Abstract submissions will open November, 2018.
All Oral Abstract Presentations will require a Disclosure of Conflict of Interest at the time of the presentation.
To ensure balance, independence, objectivity and scientific rigor, all presenters will be required to inform audience members of any possible affiliations or financial interests that may have a direct bearing on the subject matter of the presentation. Such conflicts could include, but are not limited to employment, ownership of stock, involvements with industry advisory boards, or participation in industry-sponsored clinical research. Other potential areas of real or perceived conflict of interest could include receiving honoraria or expenses from commercial organization in relation to the presentation.